World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
21854
World Ranking
17606
National Ranking
8799

Overview

Kent A. Griffith is affiliated with the University of Michigan-Ann Arbor in the United States. Their primary field of study is Medicine, with a strong concentration in Oncology and related subfields.

The scientist's research spans various areas including Oncology, Public Health, Environmental and Occupational Health, Gender Studies, Cancer Research, and Radiology, Nuclear Medicine, and Imaging.

Their research topics cover:

  • Diversity and Career in Medicine
  • Breast Cancer Treatment Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Advances in Oncology and Radiotherapy
  • Health and Medical Research Impacts
  • Global Cancer Incidence and Screening
  • Multiple Myeloma Research and Treatments

Frequent coauthors collaborating with Kent A. Griffith include:

  • Reshma Jagsi
  • Lori J. Pierce
  • James A. Hayman
  • Frank A. Vicini
  • M.M. Dominello

Their work is often published in the following venues:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • JAMA Internal Medicine
  • JCO Oncology Practice
  • Journal of Women s Health

Representative papers authored or co-authored by Kent A. Griffith include:

  • Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer, 2020, JCI Insight
  • Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA, 2023, Journal of Clinical Oncology
  • Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma, 2020, Blood
  • Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial, 2023, The Lancet Oncology
  • A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01, 2022, Cancer

Best Publications

  • Siblings, day-care attendance, and the risk of asthma and wheezing during childhood.

    Thomas M. Ball;Jose A. Castro-Rodriguez;Kent A. Griffith;Catharine J. Holberg

  • Gender Differences in Time Spent on Parenting and Domestic Responsibilities by High-Achieving Young Physician-Researchers

    Shruti Jolly;Kent A. Griffith;Rochelle DeCastro;Abigail Stewart

  • The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study.

    C. M. Baldwin;K. A. Griffith;F. J. Nieto;G. T. O'Connor

  • Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

    Ines A. Silva;Shoumei Bai;Karen McLean;Kun Yang

  • A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

    Andrzej J. Jakubowiak;Andrzej J. Jakubowiak;Dominik Dytfeld;Dominik Dytfeld;Kent A. Griffith;Daniel Lebovic

  • Sexual Harassment and Discrimination Experiences of Academic Medical Faculty.

    Reshma Jagsi;Kent A. Griffith;Rochelle Jones;Chithra R. Perumalswami

  • Gender differences in the salaries of physician researchers.

    Reshma Jagsi;Kent A. Griffith;Abigail Stewart;Dana Sambuco

  • Meta-Analysis of Survival in African American and White American Patients With Breast Cancer: Ethnicity Compared With Socioeconomic Status

    Lisa A. Newman;Kent A. Griffith;Ismail Jatoi;Michael S. Simon

  • Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.

    Feng Ming Kong;Feng Ming Kong;James A. Hayman;Kent A. Griffith;Gregory P. Kalemkerian

  • Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996.

    Robin B. Harris;Kent Griffith;Thomas E. Moon

  • Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

    Edward J. Kim;Vaibhav Sahai;Ethan V. Abel;Kent A. Griffith

  • Long-Term Financial Burden of Breast Cancer: Experiences of a Diverse Cohort of Survivors Identified Through Population-Based Registries

    Reshma Jagsi;John A.E. Pottow;Kent A. Griffith;Cathy Bradley

  • Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells

    Jennifer Rhode;Sarah K. Fogoros;Suzanna Maria Zick;Heather Wahl

  • Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation.

    Reshma Jagsi;Merav A. Ben-David;Jean M. Moran;Robin B. Marsh

  • Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors

    Anne F. Schott;Melissa D. Landis;Gabriela Dontu;Kent A. Griffith

  • Sex Differences in Attainment of Independent Funding by Career Development Awardees

    Reshma Jagsi;Amy R. Motomura;Kent A. Griffith;Soumya Rangarajan

  • Mentoring and the Career Satisfaction of Male and Female Academic Medical Faculty

    Rochelle DeCastro;Kent A. Griffith;Peter A. Ubel;Abigail Stewart

  • Full-Dose Gemcitabine and Concurrent Radiotherapy for Unresectable Pancreatic Cancer

    James D. Murphy;Saroja Adusumilli;Kent A. Griffith;Michael E. Ray

  • Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease

    Jennifer Williams;Peter C. Lucas;Kent A. Griffith;Milheon Choi

  • The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.

    Sandra C. Paek;Kent A. Griffith;Timothy M. Johnson;Vernon K. Sondak

Frequent Co-Authors

Reshma Jagsi
Reshma Jagsi University of Michigan–Ann Arbor
Lori J. Pierce
Lori J. Pierce University of Michigan–Ann Arbor
Steven J. Katz
Steven J. Katz University of Michigan–Ann Arbor
Theodore S. Lawrence
Theodore S. Lawrence University of Michigan–Ann Arbor
Dafydd G. Thomas
Dafydd G. Thomas University of Michigan–Ann Arbor
Alfred E. Chang
Alfred E. Chang University of Michigan–Ann Arbor
Peter A. Ubel
Peter A. Ubel Duke University
Ravi Vij
Ravi Vij Washington University in St. Louis
Abigail J. Stewart
Abigail J. Stewart University of Michigan–Ann Arbor
Monica Morrow
Monica Morrow Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in careers aligned with medicine but seeking flexible or alternative educational paths, online health degrees offer valuable opportunities. Today, aspiring nurses and healthcare professionals can start or advance their careers with degrees that suit different backgrounds and goals.

If you’re aiming for the highest level of academic achievement in nursing, consider exploring online nursing PhD programs, ideal for future nurse educators or researchers. Working RNs looking to expand their skills can benefit from the cheapest RN to BSN bridge options, which are both affordable and convenient.

Individuals without a nursing background but interested in fast-tracking into advanced nursing roles should review online MSN programs for non nurses. Additionally, those seeking flexible entry-level options can look at online ADN programs for non nurses, which offer an accessible start in the field.

Each pathway has unique admission requirements, timelines, and career outcomes, making it essential to choose the program that fits your aspirations and current credentials.

Best Scientists Citing Kent A. Griffith

Trending Scientists

Recently Published Articles